
Mike Page, Alexion Pharmaceuticals Invites You to SMi’s Orphan Drugs & Rare Diseases Conference
SMi Reports: Mike Page, Executive Director Global Regulatory Affairs Portfolio Products at Alexion Pharmaceuticals invites heads of medical affairs and all who are interested to […]

